Try our Advanced Search for more refined results

May 02, 2014

Lupin Pharmaceuticals Inc. v. Food and Drug Administration

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 05, 2014

    Lupin Blasts FDA's Call On Celebrex Generic Exclusivity

    Lupin Pharmaceuticals Inc. sued the U.S. Food and Drug Administration in Maryland federal court Friday over the agency's decision to grant another drug company exclusivity to make a generic version of Pfizer Inc.'s Celebrex, arguing the decision was wrong because the exclusivity period had already expired five years ago.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login